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10–320) and hypocomplementemia (C3 , 1 mg/dl, nor-LETTERS TO THE EDITOR
mal range 45–95; C4 29 mg/dl, normal range 15–55; and
CH50 39.5 U/ml, normal range 31.3–46.2). Urinary red
blood cell count was .100/high power field and urinaryEvidence of lectin
protein was 0.51 g/day. Oral bacampicillin 1500 mg per
day was administered for 10 days. Gradually, clinical andcomplement pathway
laboratory findings returned to normal.
Four weeks from the onset of symptoms renal biopsyactivation in poststreptococcal
was performed. Biopsy specimens demonstrated the typ-
ical histology of APSGN. All 16 glomeruli had increasedglomerulonephritis
numbers of mesangial and endothelial cells, which filled
Bowman’s space. Neutrophils had infiltrated the capil-To the Editor: Although many morphologic, clinical,
and serologic features of acute poststreptococcal glomer- lary lumen. Immunofluorescence microscopy revealed
the deposition of C3c and C3d in a mesangial pattern,ulonephritis (APSGN) suggest that APSGN is an im-
mune complex disease, the precise nature of the antigen- but no deposition of IgG, IgA, IgM, fibrinogen, C1q and
C4c. Immunohistological studies were performed withantibody system remains undefined, and complement
activation is primarily through the alternative rather than anti-human MBL mouse monoclonal antibody (MoAb),
anti-human MASP-1 mouse MoAb and anti-human C4dthe classical (immune complex) pathway. Recently the
third complement activation pathway, termed the “lectin MoAb. The staining patterns of MBL and C4d (Fig. 1)
were strong in all five glomeruli and seemed to be locatedpathway” (LP) had been described with starter mole-
cules consisting of mannose-binding lectin (MBL) [1] at mesangial cells and/or the area of infiltration of neu-
trophils. MASP-1 was positively stained at the same area,and two MBL-associated serine proteases, MASP-1 [2]
and MASP-2 [3]. With respect to infectious disease, LP but more weakly than MBL.
MBL recognizes high-mannose and N-acetyl-glucos-is vital as a first line of host defense, because of its
immunoglobulin-independent opsonising ability. In this amine (GlcNAc) residues on a wide range of microor-
ganisms. APSGN follows infection of the throat or skinletter, we report evidence of LP activation in a case of
typical APSGN. with group Ab-hemolytic streptococci and cell wall poly-
saccharides carry GlcNAc as the antigenic determinants.A 16-year-old man presented with nausea and macro-
hematuria 2 weeks from onset of pyrexia and sore throat. It seems likely that MBL recognizes this pathogen and
subsequently activates complement, although direct evi-Body weight was increased about 6 kg from his usual
weight and blood pressure was elevated. Laboratory data dence of the binding has not been reported. Also, MBL is
capable of recognizing galactosamine radicals to a lesserindicated the presence of leukocytosis (18,300/ml) and
degree; thus, there is a small possibility that MBL mightrenal insufficiency (blood urea nitrogen of 43.8 mg/dl,
bind to glomerular cells that had these carbohydratesserum creatinine of 1.7 mg/dl). Serology revealed high
surfaced by streptococcal neuraminidase. In any event,titer of antistreptolysin O (2865 IU/ml, normal range
Fig. 1. MBL and C4d deposition in glomer-
uli. To detect MBL, MASP-1 and C4d, we
used the avidin-biotin complex immunoperox-
idase assay (nucleus stained by hematoxylin).
(A) MBL was positively stained (brown) on
mesangial cells and/or in the area of infiltra-
tion of neutrophils in each glomerulus (magni-
fication 3100). (B) C4d were also positively
stained with the same pattern as MBL deposi-
tion (magnification 3100). MASP-1 staining
was positive in the same area, but more weakly
than MBL (not shown).
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we propose that LP activation is a major contributor renal diseases. Here we report new data that may help
explain this open field.to renal damage in APSGN, because MASP-1 directly
We examined the expression of EPO-R by immuno-activates C3 [4] and MASP-2 activates C4 [3]. Both
histochemistry using anti-EPO-R antibody (Upstate Bio-events are followed by activation of the alternative path-
technology, Inc., Lake Placid, New York, USA). Renalway, resulting in the strong deposition of C3 break down
biopsy specimens from 27 patients were examined: pa-products. In addition, lectin recognition (innate immu-
tients with minimal change disease (MCD) (N 5 4), IgAnity) is important at the very early stage in pathogen
nephropathy (IgAN) (N 5 15), membranoproliferativeinvasion, until the antigen-antibody system (acquired im-
glomerulonephritis (MPGN) (N 5 3), crescentic glomer-munity) awakens. Thus, the evidence of LP activation
ulonephritis (CrsGN) (N 5 4). The intensity of glomeru-in APSGN may explain the pathogenesis of this disease.
lar staining was scored using a scale of 0 to 4 as described
Isao Ohsawa, Hiroyuki Ohi, Morito Endo, previously [2]. In MCD, a weak immunoreactivity forTakayuki Fujita, Misao Matsushita and Teizo Fujita
EPO-R was observed in glomerular endothelial cells andDepartment of Internal Medicine II,
Nihon University School of Medicine, Tokyo, Japan on the luminal side of distal tubules (Fig. 1A). In contrast,
Department of Biochemistry, Fukushima Medical University immunoreactivity was high in glomerular endothelial
School of Medicine, Fukushima, Japan cells, mesangial cells and tubulointerstitial lesions in
IgAN, MPGN, and CrsGN. A significantly high glomeru-Correspondence to Isao Ohsawa, M.D., Department of Internal Med-
icine II, Nihon University School of Medicine, Oyaguchi-kamimachi lar staining score was noted in IgAN (2.3 6 0.4; Fig. 1B),
30-1, Itabashi-ku, Tokyo 173-8610, Japan CrsGN (2.9 6 0.4), MPGN (3.0 6 0.4) compared to those
of MCD (1.1 6 0.4).
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High expression of
erythropoietin receptor in
human chronic progressive
glomerulonephritis
To the Editor: In a recent issue of Kidney Interna-
tional, the expression of the erythropoietin-receptor
(EPO-R) was discussed in human and rat kidneys and
in several kidney cell lines [1]. However, additional stud-
ies are necessary to understand the function of this recep-
tor in vivo. Since erythropoietin (EPO) is widely used
Fig. 1. Immunohistological staining of EPO-R in MCD and IgAN. (A)in patients with renal anemia, we believe it is necessary to
Small arrowhead shows weak immunoreactivity in glomerular endothe-
investigate the role of this receptor in human progressive lial cells in MCD. Arrowhead shows immunoreactivity at the luminal
side of distal nodules. Some proximal tubules also showed diffuse weak
positive staining. (B) Increased immunoreactivity was observed in glo-
merular endothelial cells (arrowheads). The tubulointerstitial area dem-
onstrates strong immunoreactivity for EPO-R in IgAN. 1999 by the International Society of Nephrology
